Stocktoria

Denali Therapeutics Inc. DNLI

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2017-12-08 · LEI

Denali Therapeutics Inc. institutional holders

InvestorSharesValue% of company
BlackRock Finance, Inc.13,174,562$305.9M7.63%
MILLENNIUM MANAGEMENT LLC1,125,748$29.0M0.65%
CITADEL ADVISORS LLC600,071$15.4M0.35%
AQR CAPITAL MANAGEMENT LLC388,469$10.0M0.23%
Point72 Asset Management, L.P.46,400$1.2M0.03%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.